Maintenance therapy for chronic lymphocytic leukaemia-Reference-Cited by-同舟云学术

Maintenance therapy for chronic lymphocytic leukaemia

Published:2024-01-04 Issue:1 Volume:2024 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Lee Cho-Hao¹,Wu Yi-Ying¹,Huang Tzu-Chuan¹,Lin Chin²,Zou Yi-Fen³,Cheng Ju-Chun³,Chen Po-Huang⁴,Jhou Hong-Jie⁵,Ho Ching-Liang¹

Affiliation:

1. Division of Hematology and Oncology Medicine, Department of Internal Medicine; Tri-Service General Hospital, National Defense Medical Center; Taipei Taiwan

2. School of Public Health; National Defense Medical Center; Taipei Taiwan

3. Department of Pharmacy; Tri-Service General Hospital, National Defense Medical Center; Taipei Taiwan

4. Department of Internal Medicine; Tri-Service General Hospital, National Defense Medical Center; Taipei Taiwan

5. Department of Neurology; Changhua Christian Hospital; Changhua Taiwan

Publisher

Wiley

Reference227 articles.

1. Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance);Byrd J;Blood Advance,2018

2. Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial;Chanan-Khan A;Lancet Haematology,2017

3. Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study;Dartigeas;Lancet Haematology,2018

4. Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study;Fink A;Lancet Haematology,2017

5. Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients;Foa;American Journal of Hematology,2014